The UK-based start-up Sention Technologies said it has raised £3.7 million in seed funding to commercialise its battery diagnostics technologies.
The firm said it would accelerate the commercialisation of its ultrasound instrument, which is a benchtop device said to offer real-time, non-invasive battery diagnostics.
It uses proprietary scanning technology that can generate a 3D image of the internal structure of the cell.
This is combined with machine learning models to predict the health of the cell.
This data is also used to grade batteries and forecast degradation and critical issues such as thermal runaway, the company said.
The firm believe that this information is vital to improving battery safety and enhancing performance, which it said is needed for the continued development and adoption of battery technology.
It also said that this technology can lead to a reduction in battery production scrap and product recalls by having the ability to inspect the internal structure and the performance of batteries beforehand.
The company said it will also use some of the funding towards R&D for its next-generation product designed to integrate directly into production lines.
Professor Dan Brett, CEO, Sention, said: “This funding marks a significant milestone for Sention as we continue to innovate at the forefront of battery diagnostics. The support of Twin Path Ventures, and our co-investors, validates our mission to enable the energy transition by transforming the efficiency and safety of batteries and other electrochemical technologies. Batteries are transforming the way we live and leading us toward Net Zero, but they come with challenges. This investment will enable us to deliver our products to customers, making a real difference in the battery industry.”
Image: The Sention Team. Credit: Sention.
